Chronic kidney disease is a worldwide health problem often burdened by severe cardiovascular complications. Hypertension represents one of the most important risk factor in a ecting cardiovascular pro le of chronic kidney disease patients. Since renin-angiotensin-aldosterone system plays a major role in determining cardiovascular outcome, guidelines recommend the use of renin-angiotensin-aldosteron inhibitors in order to control hypertension.
Effects of dual inhibition of renin–angiotensin–aldosterone system on cardiovascular and renal outcomes. balancing the risks and the benefits / Tocci, Giuliano; Citoni, Barbara; Presta, Vivianne; Leoncini, Giovanna; Viazzi, Francesca; Bonino, Barbara; Volpe, Massimo; Pontremoli, Roberto. - In: INTERNAL AND EMERGENCY MEDICINE. - ISSN 1828-0447. - (2019). [10.1007/s11739-019-02257-3]
Effects of dual inhibition of renin–angiotensin–aldosterone system on cardiovascular and renal outcomes. balancing the risks and the benefits
Tocci, Giuliano;Citoni, Barbara;Presta, Vivianne;Volpe, Massimo;
2019
Abstract
Chronic kidney disease is a worldwide health problem often burdened by severe cardiovascular complications. Hypertension represents one of the most important risk factor in a ecting cardiovascular pro le of chronic kidney disease patients. Since renin-angiotensin-aldosterone system plays a major role in determining cardiovascular outcome, guidelines recommend the use of renin-angiotensin-aldosteron inhibitors in order to control hypertension.| File | Dimensione | Formato | |
|---|---|---|---|
|
Tocci_Effects_2019.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
432.51 kB
Formato
Adobe PDF
|
432.51 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
